 |
Alglucerase injection |
|---|---|
| Trade Name | Ceredase |
| Orphan Indication | Replacement therapy in patients with Type II and III Gaucher's disease |
| USA Market Approval | USA |
| USA Designation Date | 1995-07-21 00:00:00 |
| Sponsor | Genzyme Corporation;One Kendall Square;Cambridge, Massachusetts, 02139 |
